Future investigations should focus on delineating the precise mechanisms of CHAC1 in ferroptosis regulation within different cancer contexts and exploring pharmacological approaches to modulate CHAC1 expression (e.g., activators) for therapeutic benefit. The gene discussed is CHAC1; the disease is cancer.